Lv11
48 积分 2023-07-11 加入
Liquidambaric acid inhibits cholangiocarcinoma progression by disrupting the STAMBPL1/NRF2 positive feedback loop
7天前
已完结
Epidemiology of paraneoplastic neurological syndromes: a population-based study
1个月前
已完结
Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial)
1个月前
已完结
Curdione alleviates renal fibrosis through Fblim1-dependent inhibition of the TGF-β1/Smad3 signaling pathway
3个月前
已完结
Neuropeptide Precursor VGF Promotes Neuroendocrine Differentiation and Cancer-Associated Fibroblast Activation in Small Cell Lung Cancer
5个月前
已完结
ACSL family: The regulatory mechanisms and therapeutic implications in cancer
7个月前
已完结
Anlotinib enhanced CD8+ T cell infiltration via induction of CCL5 improves the efficacy of PD-1/PD-L1 blockade therapy in lung cancer
7个月前
已完结
Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study
7个月前
已完结
Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
8个月前
已完结
Current landscape of cross-line immune checkpoint blockade for cancer treatment
8个月前
已完结
皖公网安备34019202002308
